Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study

References

• ADVANCE Collaborative GroupEffects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet20073708294017765963
   PubMed Web of Science ®Google Scholar
• AjjanRCarterAMSomaniREthnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndromeJ Thromb Haemost200775460
   Google Scholar
• AlbertiKGZimmetPShawJMetabolic syndrome – a new worldwide definitionLancet200536610596216182882
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPDefinition, diagnosis and classification of diabetes and its complications. Part I: diagnosis and classification of diabetes provisional report of a WHO consultationDiabet Med199815539539686693
   PubMed Web of Science ®Google Scholar
• AsmarRGLondonGMO’RourkeMEImprovement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenololHypertension200138922611641310
   PubMed Web of Science ®Google Scholar
• BalkauBCharlesMAComments on the provisional report from the WHO consultation. European Group for the Study of Insulin ResistanceDiabet Med199916442310342346
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCCalderonAAdequacy of the treatment of hypertensive patients with metabolic syndromeMed Clin (Barc)20071286475117537361
   PubMed Web of Science ®Google Scholar
• Borch-JohnsenKThe metabolic syndrome in a global perspective. The public health impact -secondary publicationDan Med Bull200754157917521535
   PubMedGoogle Scholar
• ChoiKMKimSMKimYEInternational Diabetes federation. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education program and International Diabetes Federation definitions in the Korean populationMetabolism200756552817379016
   PubMed Web of Science ®Google Scholar
• CuspidiCMeaniSValerioCAge and target organ damage in essentialhypertension: role of the metabolic syndromeAm J Hypertens20072029630317324743
   PubMed Web of Science ®Google Scholar
• DayCMetabolic syndrome, or What you will: definition and epidemiologyDiab Vasc Dis Res2007432817469041
   PubMedGoogle Scholar
• De JonghRTSernéEHIjzermanRGImpaired microvascular function in obesity. Implications for obesity associated microangiopathy, hypertension and insulin resistanceCirculation200410925293515136505
   PubMed Web of Science ®Google Scholar
• ESC-ESHGuidelines for the Management of Arterial Hypertension. 2007. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)J Hypertens20072511058717563527
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• FerraraLACardoniOManciniMMetabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio StudyJ Hum Hypertens2007b2179580117508012
   PubMed Web of Science ®Google Scholar
• FerraraLAGuidaLFerraraFCardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndromeJ Hum Hypertens2007a217293517525708
   PubMed Web of Science ®Google Scholar
• FordESGilesWHDietzWHPrevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination SurveyJAMA2002287356911790215
   PubMed Web of Science ®Google Scholar
• Garcia-PuigJRuilopeLMLuqueMAVANT Study Group Investigators. Glucose metabolism in patients with essential hypertensionAm J Med20061193182616564774
   PubMed Web of Science ®Google Scholar
• GrundySMBrewerHBCleemanJLDefinition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/ AHA conference on scientific issues related to definitionsCirculation2004109433814744958
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIDanielsSRDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementCirculation200511227355216157765
   PubMed Web of Science ®Google Scholar
• HuGfor the DECODE studyPrevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and womenArch Intern Med200416410667615159263
   PubMed Web of Science ®Google Scholar
• JuliusSGudbrandssonTJamersonKThe hemodynamic link between insulin resistance and hypertensionJ Hypertens1991998361661769
   PubMed Web of Science ®Google Scholar
• KelishadiRDerakhstanRSabetBThe metabolic syndrome in hypertensive and normotensive subjects: the Isfahan Healthy Heart ProgrammeAnn Acad Med Singapore200534243915902345
   PubMed Web of Science ®Google Scholar
• KelishadiRChildhood overweight, obesity, and the metabolic syndrome in developing countriesEpidemiol Rev200729627617478440
   PubMed Web of Science ®Google Scholar
• LakkaHMLaaksonnenDELakkaTAThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged menJAMA200228827091612460094
   PubMed Web of Science ®Google Scholar
• LeonciniGRattoEViazziFMetabolic syndrome is associated with early signs of organ damage in nondiabetic hypertensive patientsJ Intern Med20052574546015836662
   PubMed Web of Science ®Google Scholar
• LeonciniGRattoEViazziFMetabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertensionJ Hum Hypertens200721802717541383
   PubMed Web of Science ®Google Scholar
• LevyBIDuriezMSamuelJLCoronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitorAm J Hypertens20011471311206683
   PubMed Web of Science ®Google Scholar
• LondonGMAsmarRGO’RourkeMMechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenololJ Am Coll Cardiol20044392914715189
   PubMed Web of Science ®Google Scholar
• MitrakouAWomen’s health and the metabolic syndromeAnn NY Acad Sci20061092334817308131
   PubMed Web of Science ®Google Scholar
• MouradJJHanonODeverreJRImprovement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET studyJ Renin Angiotens Aldoster Syst20034945
   PubMed Web of Science ®Google Scholar
• MulèGCottoneSNardiEMetabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damageMinerva Cardioangiol2006541739416778751
   PubMedGoogle Scholar
• MulèGNardiECottoneSInfluence of metabolic syndrome on hypertension-related target organ damageJ Intern Med20052575031315910554
   PubMed Web of Science ®Google Scholar
• MulèGNardiECottoneSRelationship of metabolic syndrome with pulse pressure in patients with essential hypertensionAm J Hypertens20072019720317261467
   PubMed Web of Science ®Google Scholar
• NavarroJRedonJCea-CalvoLMetabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA studyBlood Press20071620717453748
   PubMed Web of Science ®Google Scholar
• NilssonPMEngströmGHedbladBThe metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects. A population-based study comparing three different definitionsDiabet Med2007244647217381496
   PubMed Web of Science ®Google Scholar
• QiaoQGaoWZhangLMetabolic syndrome and cardiovascular diseaseAnn Clin Biochem2007442326317456293
   PubMed Web of Science ®Google Scholar
• ReavenGMBanting lecture 1988: role of insulin resistance in human diseaseDiabetes19883715956073056758
   PubMed Web of Science ®Google Scholar
• RodillaEGonzalezCCostaJANew definition of metabolic syndrome: does it have the same cardiovascular risk?Rev Clin Esp2007207697417397565
   PubMed Web of Science ®Google Scholar
• RoyerMCastelo-BrancoCBlümelJEThe US National Cholesterol Education programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American womenClimateric20071016470
   PubMed Web of Science ®Google Scholar
• SchillaciGPirroMVandoGPrognostic value of the metabolic syndrome in essential hypertensionJ Am Coll Cardiol20044318172215145106
   PubMed Web of Science ®Google Scholar
• TamakiSNakamuraYYoshinoTThe association between morning hypertension and metabolic syndrome in hypertensive patientsHypertens Res200629783817283865
   PubMed Web of Science ®Google Scholar
• TonkinRThe X factor: obesity and the metabolic syndromeThe Science and Public Affairs Forum2003World Health organization (1999) Report of a WHO consultation: definition of metabolic syndrome in definition, diagnosis, and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitusGenevaWorld Health Organization, Department of Noncommunicable Disease Surveillance
   Google Scholar